Optimal use of bisphosphonates in patients with multiple myeloma

Blood. 2013 Apr 25;121(17):3325-8. doi: 10.1182/blood-2012-10-435750. Epub 2013 Feb 13.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Bone Diseases / drug therapy*
  • Bone Diseases / etiology
  • Diphosphonates / therapeutic use*
  • Humans
  • Multiple Myeloma / complications*
  • Multiple Myeloma / therapy
  • Prognosis

Substances

  • Bone Density Conservation Agents
  • Diphosphonates